Harvard Bioscience Inc expected to post earnings of 5 cents a share - Earnings Preview

Harvard Bioscience

10/03/2025 12:56

Harvard Bioscience Inc HBIO.OQ HBIO.O is expected to show a fall in quarterly revenue when it reports  results on March 12 for the period ending December 31 2024

The Holliston Massachusetts-based  company is expected to report a 14.2% decrease in revenue to $24.15 million from $28.15 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on November 7 2024, for the period ended December 31, was for revenue between $23.00 million and $26.00 million.

​LSEG's mean analyst estimate for Harvard Bioscience Inc is for earnings of 5 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Harvard Bioscience Inc is $6.25​, above​ its last closing price of $0.82. ​​​

The company's guidance on November 7 2024 for the period ended December 31 was for Earnings before Interest, Taxes, Depreciation and Amortization of between USD23 million and USD4.16 million.The company's guidance on November 7 2024 for the period ended December 31 was for gross profit margin between USD59% and USD60%.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
0.02
0.03
-0.02
Missed
-175
Jun. 30 2024
0.03
0.05
0.00
Missed
-100
Mar. 31 2024
0.02
0.02
0.02
Met
-14.3​
Dec. 31 2023
0.05
0.05
0.04
Missed
-20
​​Sep. 30 2023
0.04
0.04
0.01
Missed
-75
Jun. 30 2023
0.07
0.06
0.04
Missed
-36.8​
Mar. 31 2023
0.05
0.05
0.06
Beat
20
Dec. 31 2022
0.08
0.03
0.04
Beat
20

This summary was machine generated March 10 at 12:56 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)